-
1
-
-
0018308190
-
Clinical features and natural history of Crohn’s disease (NCCDS)
-
Mekhjian HS, Switz DM, Melnyk CS, Rankin GB, Brooks RK. Clinical features and natural history of Crohn’s disease (NCCDS). Gastroenterology 1979; 77: 898-906.
-
(1979)
Gastroenterology
, vol.77
, pp. 898-906
-
-
Mekhjian, H.S.1
Switz, D.M.2
Melnyk, C.S.3
Rankin, G.B.4
Brooks, R.K.5
-
2
-
-
0021966698
-
European Cooperative Crohn’s Disease Study (ECCDS): Clinical features and natural history
-
Steinhardt HJ, Loeschke K, Kasper H, Holtermuller KH, Schafer H. European Cooperative Crohn’s Disease Study (ECCDS): clinical features and natural history. Digestion 1985; 31: 97-108.
-
(1985)
Digestion
, vol.31
, pp. 97-108
-
-
Steinhardt, H.J.1
Loeschke, K.2
Kasper, H.3
Holtermuller, K.H.4
Schafer, H.5
-
3
-
-
0028823950
-
Identifying patients with a high risk of relapse in quiescent Crohn’s disease
-
Sahmound T, Hoctin-Boes G, Modigliani R, Bitoun A, Colombel JF, Soule JC. et al. Identifying patients with a high risk of relapse in quiescent Crohn’s disease. Gut 1995; 37: 811-818.
-
(1995)
Gut
, vol.37
, pp. 811-818
-
-
Sahmound, T.1
Hoctin-Boes, G.2
Modigliani, R.3
Bitoun, A.4
Colombel, J.F.5
Soule, J.C.6
-
4
-
-
0023839955
-
Diminished neutrophil function in Crohn’s disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content
-
Verspaget HW, Pena AS, Weterman IT, Lamers CBHW. Diminished neutrophil function in Crohn’s disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content. Gut 1988; 29: 223-228.
-
(1988)
Gut
, vol.29
, pp. 223-228
-
-
Verspaget, H.W.1
Pena, A.S.2
Weterman, I.T.3
Lamers, C.B.H.W.4
-
5
-
-
0000802315
-
Gut lavage protein concentrations: Objective measures of disease activity in inflammatory bowel disease
-
Choudari CP, O’Mahony S, Brydon G, Mwantembe O, Ferguson A. Gut lavage protein concentrations: objective measures of disease activity in inflammatory bowel disease. Gastroenterology 1990; 99: 1380-1387.
-
(1990)
Gastroenterology
, vol.99
, pp. 1380-1387
-
-
Choudari, C.P.1
O’Mahony, S.2
Brydon, G.3
Mwantembe, O.4
Ferguson, A.5
-
6
-
-
0027113096
-
Haemoglobin in gut lavage as a measure of gastrointestinal blood loss
-
Brydon WG, Ferguson A. Haemoglobin in gut lavage as a measure of gastrointestinal blood loss. Lancet 1992; 340: 1381-1382.
-
(1992)
Lancet
, vol.340
, pp. 1381-1382
-
-
Brydon, W.G.1
Ferguson, A.2
-
7
-
-
0028921538
-
Investigation of neutrophil migration into the gut by cytology of whole gut lavage fluid
-
Handy LM, Ghosh S, Ferguson A. Investigation of neutrophil migration into the gut by cytology of whole gut lavage fluid. Eur J Gastroenterol Hepatol 1995; 7: 53-58.
-
(1995)
Eur J Gastroenterol Hepatol
, vol.7
, pp. 53-58
-
-
Handy, L.M.1
Ghosh, S.2
Ferguson, A.3
-
8
-
-
0029762626
-
Investigation of neutrophils in the gut lumen by assay of granulocyte elastase in whole gut lavage fluid
-
Handy LM, Ghosh S, Ferguson A. Investigation of neutrophils in the gut lumen by assay of granulocyte elastase in whole gut lavage fluid. Scand J Gastroenterol 1996; 31: 700-705.
-
(1996)
Scand J Gastroenterol
, vol.31
, pp. 700-705
-
-
Handy, L.M.1
Ghosh, S.2
Ferguson, A.3
-
9
-
-
0026589748
-
Enhanced mucosal cytokine production in inflammatory bowel disease
-
Pullman WE, Elsbury S, Kobayashi M, Hapel AJ, Doe WF. Enhanced mucosal cytokine production in inflammatory bowel disease. Gastroenterology 1992; 102: 529-537.
-
(1992)
Gastroenterology
, vol.102
, pp. 529-537
-
-
Pullman, W.E.1
Elsbury, S.2
Kobayashi, M.3
Hapel, A.J.4
Doe, W.F.5
-
10
-
-
0028319023
-
IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn’s disease
-
Mitsuyama K, Toyonaga A, Sasaki E, Watanabe K, Tateishi H, Nishiyama T. et al. IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn’s disease. Clin Exp Immunol 1994; 96: 432-436.
-
(1994)
Clin Exp Immunol
, vol.96
, pp. 432-436
-
-
Mitsuyama, K.1
Toyonaga, A.2
Sasaki, E.3
Watanabe, K.4
Tateishi, H.5
Nishiyama, T.6
-
11
-
-
0030795385
-
Gut lavage IgG and interleukin 1 receptor antagonist:Interleukin 1β ratio as markers of intestinal inflammation in children with inflammatory bowel disease
-
Troncone R, Caputo N, Campanozzi A, Cucciardi M, Esposito V, Russo R. et al. Gut lavage IgG and interleukin 1 receptor antagonist:interleukin 1β ratio as markers of intestinal inflammation in children with inflammatory bowel disease. Gut 1997; 41: 60-65.
-
(1997)
Gut
, vol.41
, pp. 60-65
-
-
Troncone, R.1
Caputo, N.2
Campanozzi, A.3
Cucciardi, M.4
Esposito, V.5
Russo, R.6
-
12
-
-
0028818575
-
Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements
-
Croft NM, Marshall TG, Ferguson A. Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements. Lancet 1995; 346: 1265-1267.
-
(1995)
Lancet
, vol.346
, pp. 1265-1267
-
-
Croft, N.M.1
Marshall, T.G.2
Ferguson, A.3
-
13
-
-
0031706098
-
Intestinal permeability and inflammation in patients on NSAIDs
-
Sigthorsson G, Tibble J, Hayllar J, Menzies I, MacPherson A, Moots R. et al. Intestinal permeability and inflammation in patients on NSAIDs. Gut 1998; 43: 506-511.
-
(1998)
Gut
, vol.43
, pp. 506-511
-
-
Sigthorsson, G.1
Tibble, J.2
Hayllar, J.3
Menzies, I.4
MacPherson, A.5
Moots, R.6
-
14
-
-
0020515113
-
l-Pyroglutamyl- l-propyl- l-valine-p-nitroanilide, a highly specific substrate for granulocyte elastase
-
Kramps JA, van Twisk C, van der Linden AC. l-Pyroglutamyl- l-propyl- l-valine-p-nitroanilide, a highly specific substrate for granulocyte elastase. Scand J Clin Lab Invest 1983; 43: 427-432.
-
(1983)
Scand J Clin Lab Invest
, vol.43
, pp. 427-432
-
-
Kramps, J.A.1
van Twisk, C.2
van der Linden, A.C.3
-
15
-
-
0027369395
-
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
-
Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993; 75: 253-261.
-
(1993)
Cell
, vol.75
, pp. 253-261
-
-
Sadlack, B.1
Merz, H.2
Schorle, H.3
Schimpl, A.4
Feller, A.C.5
Horak, I.6
-
16
-
-
0027521572
-
Interleukin-10-deficient mice develop chronic enterocolitis
-
Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75: 263-274.
-
(1993)
Cell
, vol.75
, pp. 263-274
-
-
Kuhn, R.1
Lohler, J.2
Rennick, D.3
Rajewsky, K.4
Muller, W.5
-
17
-
-
0031915148
-
Early lesions of recurrent Crohn’s disease caused by infusion of intestinal contents in excluded ileum
-
D’Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn’s disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998; 114: 262-267.
-
(1998)
Gastroenterology
, vol.114
, pp. 262-267
-
-
D’Haens, G.R.1
Geboes, K.2
Peeters, M.3
Baert, F.4
Penninckx, F.5
Rutgeerts, P.6
-
18
-
-
0025744361
-
Gut lavage fluid proteins as markers of activity of inflammatory bowel disease
-
O’Mahony S, Choudari CP, Barton JR, Walker S, Ferguson A. Gut lavage fluid proteins as markers of activity of inflammatory bowel disease. Scand J Gastroenterol 1991; 26: 940-944.
-
(1991)
Scand J Gastroenterol
, vol.26
, pp. 940-944
-
-
O’Mahony, S.1
Choudari, C.P.2
Barton, J.R.3
Walker, S.4
Ferguson, A.5
-
19
-
-
0029955649
-
Strengths and limitations of the Crohn’s disease activity index, revealed by an objective gut lavage test of gastrointestinal protein loss
-
Acciuffi S, Ghosh S, Ferguson A. Strengths and limitations of the Crohn’s disease activity index, revealed by an objective gut lavage test of gastrointestinal protein loss. Aliment Pharmacol Ther 1997; 10: 321-326.
-
(1997)
Aliment Pharmacol Ther
, vol.10
, pp. 321-326
-
-
Acciuffi, S.1
Ghosh, S.2
Ferguson, A.3
-
20
-
-
0031409459
-
Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease
-
Levy AM, Gleich GJ, Sandborn WJ, Tremaine WJ, Steiner BL, Phillips SF. Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease. Mayo Clin Proc 1997; 72: 117-123.
-
(1997)
Mayo Clin Proc
, vol.72
, pp. 117-123
-
-
Levy, A.M.1
Gleich, G.J.2
Sandborn, W.J.3
Tremaine, W.J.4
Steiner, B.L.5
Phillips, S.F.6
-
21
-
-
0030007163
-
Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: Reflection of mucosal inflammation
-
Hommes DW, Meenan J, de Haas M, ten Kate FJ, von dem Borne AE, Tytgat GN. et al. Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammation. Gut 1996; 38: 564-567.
-
(1996)
Gut
, vol.38
, pp. 564-567
-
-
Hommes, D.W.1
Meenan, J.2
De Haas, M.3
Ten Kate, F.J.4
Von Dem Borne, A.E.5
Tytgat, G.N.6
-
22
-
-
0029071722
-
Products of enteropathogenic E. coli inhibit lymphocyte activation and lymphokine production
-
Klapproth J-M, Donnenberg MS, Abraham JM, Mobley HLT, James SP. Products of enteropathogenic E. coli inhibit lymphocyte activation and lymphokine production. Infect Immun 1995; 63: 2248-2254.
-
(1995)
Infect Immun
, vol.63
, pp. 2248-2254
-
-
Klapproth, J.-M.1
Donnenberg, M.S.2
Abraham, J.M.3
Mobley, H.L.T.4
James, S.P.5
-
23
-
-
0024421453
-
Neutrophil activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils
-
Baggiolini M, Walz A, Kunkel SL. Neutrophil activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84: 1045-1049.
-
(1989)
J Clin Invest
, vol.84
, pp. 1045-1049
-
-
Baggiolini, M.1
Walz, A.2
Kunkel, S.L.3
-
24
-
-
0022391855
-
The role of phagocytes in inflammatory bowel disease
-
Hermanowicz A, Gibson PR, Jewell DP. The role of phagocytes in inflammatory bowel disease. Clin Sci 1985; 69: 241-249.
-
(1985)
Clin Sci
, vol.69
, pp. 241-249
-
-
Hermanowicz, A.1
Gibson, P.R.2
Jewell, D.P.3
-
25
-
-
0031466266
-
Review article: Pathobiology of neutrophil interactions with intestinal epithelia
-
Madara JL. Review article: Pathobiology of neutrophil interactions with intestinal epithelia. Aliment Pharmacol Ther 1997; 11: 57-63.
-
(1997)
Aliment Pharmacol Ther
, vol.11
, pp. 57-63
-
-
Madara, J.L.1
-
26
-
-
0021091510
-
Quantitative fecal indium 111-labeled leukocyte excretion in the assessment of disease in Crohn’s disease
-
Saverymuttu SH, Peters AM, Lavender JP, Pepys MB, Hodgson HJF, Chadwick VS. Quantitative fecal indium 111-labeled leukocyte excretion in the assessment of disease in Crohn’s disease. Gastroenterology 1983; 85: 1333-1339.
-
(1983)
Gastroenterology
, vol.85
, pp. 1333-1339
-
-
Saverymuttu, S.H.1
Peters, A.M.2
Lavender, J.P.3
Pepys, M.B.4
Hodgson, H.J.F.5
Chadwick, V.S.6
-
27
-
-
0022631955
-
Clinical remission in Crohn’s disease- assessment using faecal 111-In granulocyte excretion
-
Saverymuttu SH. Clinical remission in Crohn’s disease- assessment using faecal 111-In granulocyte excretion. Digestion 1986; 33: 74-79.
-
(1986)
Digestion
, vol.33
, pp. 74-79
-
-
Saverymuttu, S.H.1
-
28
-
-
0025818065
-
The effect of elemental diet on intestinal permeability and inflammation in Crohn’s disease
-
Teahon K, Smethurst P, Pearson M, Levi AJ, Bjarnason I. The effect of elemental diet on intestinal permeability and inflammation in Crohn’s disease. Gastroenterology 1991; 101: 84-89.
-
(1991)
Gastroenterology
, vol.101
, pp. 84-89
-
-
Teahon, K.1
Smethurst, P.2
Pearson, M.3
Levi, A.J.4
Bjarnason, I.5
-
29
-
-
0022621499
-
Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease
-
Saverymuttu SH, Camilleri M, Rees H, Lavender JP, Hodgson HJF, Chadwick VS. Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. Gastroenterology 1986; 90: 1121-1128.
-
(1986)
Gastroenterology
, vol.90
, pp. 1121-1128
-
-
Saverymuttu, S.H.1
Camilleri, M.2
Rees, H.3
Lavender, J.P.4
Hodgson, H.J.F.5
Chadwick, V.S.6
|